October 1, 2018 07:12 AM EDTUpdated 08:02 AM
People
Peer Review

Ian Read taps his care­ful­ly groomed suc­ces­sor Al­bert Bourla as the next Pfiz­er CEO. What's his fu­ture look like?

John Carroll

Editor & Founder

Al­bert Bourla spent 25 years get­ting to the top at Pfiz­er, and now he’ll com­plete the last stride in­to the CEO’s of­fice, tak­ing con­trol of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times